Last reviewed · How we verify
Panadeine® Extra
Panadeine Extra contains paracetamol and codeine, which work together to relieve pain and reduce fever.
Panadeine Extra contains paracetamol and codeine, which work together to relieve pain and reduce fever. Used for Relief of moderate to severe pain, Reduction of fever.
At a glance
| Generic name | Panadeine® Extra |
|---|---|
| Also known as | Acetaminophen/codeine, Paracetamol/codeine |
| Sponsor | Reckitt Benckiser LLC |
| Drug class | Opioid analgesic |
| Target | Opioid receptors |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 3 |
Mechanism of action
Paracetamol is an analgesic and antipyretic that works by inhibiting the production of prostaglandins, while codeine is an opioid analgesic that binds to opioid receptors in the brain, spinal cord, and other areas to reduce pain perception.
Approved indications
- Relief of moderate to severe pain
- Reduction of fever
Common side effects
- Nausea
- Dizziness
- Constipation
- Vomiting
- Headache
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Panadeine® Extra CI brief — competitive landscape report
- Panadeine® Extra updates RSS · CI watch RSS
- Reckitt Benckiser LLC portfolio CI